Methocarbamol Injection USP 1 recalled over sterility concerns

Recall date

March 21, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Somerset Therapeutics Private Limited recalls Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset The…

Recall number

D-0354-2025

FDA classification

Class II

Brand / firm

Somerset Therapeutics Private Limited

Sold / distributed

U.S. Nationwide

Why it was recalled

Lack of Assurance of Sterility: Media fill with bacterial contamination

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)